Inflammatory Heart Disease Diagnosis and Treatment Market
Inflammatory Heart Disease Diagnosis and Treatment Market Size, Share & Trends Analysis Report by Type (Endocarditis, Myocarditis, and Pericarditis), by Diagnosis (Imaging Tests, Laboratory Tests, Electrocardiography (ECG or EKG), Biopsy, and Others) and by Treatment (Medications, and Surgical Procedure) Forecast Period (2024-2031)
Inflammatory heart disease diagnosis and treatment market is anticipated to grow at a significant CAGR of 8.4% during the forecast period (2024-2031). The demand for diagnostic and treatment options is driven by the rise in inflammatory heart diseases and the aging population. The market is growing as a result of developments in treatment choices, new drugs, and diagnostic technology. Market expansion is further supported by rising healthcare spending, public awareness, government support, and economic progress in emerging markets.
Market Dynamics
Increasing Prevalence of Cardiovascular Diseases
The global increase in cardiovascular diseases, including inflammatory conditions, is primarily driven by elements such as aging populations, poor diets, sedentary lives, and obesity. According to the World Heart Federation, in March 2023, cardiovascular diseases (CVDs) have been the leading cause of mortality globally, with 20.5 million mortalities in 2021, accounting for one-third of all mortalities. In April 2024, Northwestern University, the University of Michigan, and the University of Pittsburgh lead a $15 million project to study inflammation's role in cardiac and brain diseases, aiming to understand body response and prevent or treat inflammation-driven cardiovascular diseases. In June 2023, the US FDA approved LODOCO, a 0.5 mg tablet anti-inflammatory drug, to reduce cardiac event risk in adults with established atherosclerotic cardiovascular disease (ASCVD) by 31%. LODOCO targets residual inflammation as a cause and can be used alone or in combination with cholesterol-lowering medications.
Market Segmentation
- Based on the type, the market is segmented into endocarditis, myocarditis, and pericarditis.
- Based on the diagnosis, the market is segmented into imaging tests, laboratory tests, electrocardiography (ECG or EKG), biopsy, and others (cardiac catheterization, and pericardiocentesis).
- Based on the treatment, the market is segmented into medications and surgical procedures.
Imaging Tests is Projected to Hold the Largest Segment
The high demand for imaging tests globally to diagnose inflammatory heart diseases is contributing to the high share of this market segment. According to the NHS England org., in November 2023, in the year leading up to March 2023, a total of 45.0 million imaging tests were conducted in England, marking a 2.2% increase from 44.0 million in the previous year. Plain Radiography (X-ray) accounted for the largest share with 22.0 million tests, showing a 1.0% rise. Other notable increases were observed in Ultrasound (10.3 million, up 1.8%), CT scans (7.1 million, up 5.5%), and MRI scans (4.1 million, up 6.2%), while Fluoroscopy and Nuclear Medicine saw declines of 2.4% and 3.3%, respectively.
Regional Outlook
The global inflammatory heart disease diagnosis and treatment Market is further segmented based on geography including North America (the US, and Canada), Europe (the UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Global Inflammatory Heart Disease Diagnosis and Treatment Market Growth by Region 2024-2031
North America Holds Major Market Share
The market for inflammatory heart disease is projected to grow as a result of increased healthcare spending, leading to easier to adopt new technologies and providing access to advanced diagnostic and treatment possibilities. According to the American Medical Association. In July 2024, health spending in the US increased by 4.1% in 2022, totaling $4.5 trillion or $13,493 per capita. This growth rate aligns with pre-pandemic levels. Although there were substantial increases in National Health Expenditures (NHE) due to pandemic management, these declined in 2021 as the utilization of medical goods and services rebounded, bringing 2022 spending patterns closer to those seen before the pandemic.
Market Players Outlook
*Note: Major Players Sorted in No Particular Order.
The major companies serving the global inflammatory heart disease diagnosis and treatment market include Abbott Laboratories, Novartis Pharma AG, Johnson & Johnson Services, Inc., Pfizer Inc., and Siemens Healthcare Pvt. Ltd. among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market.
Recent Developments
- In March 2022, Pfizer acquired Arena Pharmaceuticals, which includes a portfolio of promising therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, a selective S1P receptor modulator for immuno-inflammatory diseases, and two cardiovascular assets.
The Report Covers
- Market value data analysis of 2023 and forecast to 2031.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the inflammatory heart disease diagnosis and treatment Market. Based on the availability of data, information related to new products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Industry Trends
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Abbott Laboratories
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Novartis Pharma AG
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Johnson & Johnson Services, Inc
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Pfizer Inc.
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Siemens Healthcare Pvt. Ltd.
3.6.1. Overview
3.6.2. Financial Analysis
3.6.3. SWOT Analysis
3.6.4. Recent Developments
3.7. Key Strategy Analysis
4. Market Segmentation
4.1. Global Inflammatory Heart Disease Diagnosis and Treatment Market by Type
4.1.1. Endocarditis
4.1.2. Myocarditis
4.1.3. Pericarditis
4.2. Global Inflammatory Heart Disease Diagnosis Market by Type
4.2.1. Imaging Tests
4.2.2. Laboratory Tests
4.2.3. Electrocardiography (ECG or EKG)
4.2.4. Biopsy
4.2.5. Others (Cardiac Catheterization, and Pericardiocentesis)
4.3. Global Inflammatory Heart Disease Treatment Market by Type
4.3.1. Medications
4.3.2. Surgical Procedure
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
5.4.1. Latin America
5.4.2. Middle East and Africa
6. Company Profiles
6.1. Amgen Inc.
6.2. Astellas Pharma US, Inc.
6.3. AstraZeneca
6.4. Becton, Dickinson, and Co.
6.5. Bio-Rad Laboratories, Inc.
6.6. Boehringer Ingelheim International GmbH
6.7. Boston Scientific Corp.
6.8. Bristol Myers Squibb
6.9. Canon Medical Systems Corp.
6.10. Eli Lilly and Co.
6.11. F. Hoffmann-La Roche Ltd
6.12. GE Healthcare Technologies Inc.
6.13. Hikma Pharmaceuticals PLC
6.14. Koninklijke Philips N.V.
6.15. Mayo Clinic
6.16. Medtronic plc
6.17. Merck Group
6.18. Otsuka Holdings Co., Ltd.
6.19. Sanofi SA
6.20. Sun Pharmaceutical Industries Ltd.
6.21. Takeda Pharmaceutical Co. Ltd.
1. Global Inflammatory Heart Disease Diagnosis and Treatment Market Research And Analysis By Type, 2023-2031 ($ Million)
2. Global Endocarditis Diagnosis and Treatment Market Research And Analysis By Region, 2023-2031 ($ Million)
3. Global Myocarditis Diagnosis and Treatment Market Research And Analysis By Region, 2023-2031 ($ Million)
4. Global Pericarditis Diagnosis and Treatment Market Research And Analysis By Region, 2023-2031 ($ Million)
5. Global Inflammatory Heart Disease Diagnosis Market Research And Analysis By Type, 2023-2031 ($ Million)
6. Global Imaging Tests for Inflammatory Heart Disease Market Research And Analysis By Region, 2023-2031 ($ Million)
7. Global Laboratory Tests for Inflammatory Heart Disease Market Research And Analysis By Region, 2023-2031 ($ Million)
8. Global Electrocardiography for Inflammatory Heart Disease Market Research And Analysis By Region, 2023-2031 ($ Million)
9. Global Biopsy for Inflammatory Heart Disease Market Research And Analysis By Region, 2023-2031 ($ Million)
10. Global Other Inflammatory Heart Disease Diagnosis Test Market Research And Analysis By Region, 2023-2031 ($ Million)
11. Global Inflammatory Heart Disease Treatment Market Research And Analysis By Type, 2023-2031 ($ Million)
12. Global Inflammatory Heart Disease Medications Market Research And Analysis By Region, 2023-2031 ($ Million)
13. Global Inflammatory Heart Disease Surgical Procedure Market Research And Analysis By Region, 2023-2031 ($ Million)
14. Global Inflammatory Heart Disease Diagnosis and Treatment Market Research And Analysis By Region, 2023-2031 ($ Million)
15. North American Inflammatory Heart Disease Diagnosis and Treatment Market Research And Analysis By Country, 2023-2031 ($ Million)
16. North American Inflammatory Heart Disease Diagnosis and Treatment Market Research And Analysis By Type, 2023-2031 ($ Million)
17. North American Inflammatory Heart Disease Diagnosis Market Research And Analysis By Type, 2023-2031 ($ Million)
18. North American Inflammatory Heart Disease Treatment Market Research And Analysis By Type, 2023-2031 ($ Million)
19. European Inflammatory Heart Disease Diagnosis and Treatment Market Research And Analysis By Country, 2023-2031 ($ Million)
20. European Inflammatory Heart Disease Diagnosis and Treatment Market Research And Analysis By Type, 2023-2031 ($ Million)
21. European Inflammatory Heart Disease Diagnosis Market Research And Analysis By Type, 2023-2031 ($ Million)
22. European Inflammatory Heart Disease Treatment Market Research And Analysis By Type, 2023-2031 ($ Million)
23. Asia-Pacific Inflammatory Heart Disease Diagnosis and Treatment Market Research And Analysis By Country, 2023-2031 ($ Million)
24. Asia-Pacific Inflammatory Heart Disease Diagnosis and Treatment Market Research And Analysis By Type, 2023-2031 ($ Million)
25. Asia-Pacific Inflammatory Heart Disease Diagnosis Market Research And Analysis By Type, 2023-2031 ($ Million)
26. Asia-Pacific Inflammatory Heart Disease Treatment Market Research And Analysis By Type, 2023-2031 ($ Million)
27. Rest Of The World Inflammatory Heart Disease Diagnosis and Treatment Market Research And Analysis By Region, 2023-2031 ($ Million)
28. Rest Of The World Inflammatory Heart Disease Diagnosis and Treatment Market Research And Analysis By Type, 2023-2031 ($ Million)
29. Rest Of The World Inflammatory Heart Disease Diagnosis Market Research And Analysis By Type, 2023-2031 ($ Million)
30. Rest Of The World Inflammatory Heart Disease Treatment Market Research And Analysis By Type, 2023-2031 ($ Million)
1. Global Inflammatory Heart Disease Diagnosis and Treatment Market Share By Type, 2023 Vs 2031 (%)
2. Global Endocarditis Diagnosis and Treatment Market Share By Region, 2023 Vs 2031 (%)
3. Global Myocarditis Diagnosis and Treatment Market Share By Region, 2023 Vs 2031 (%)
4. Global Pericarditis Diagnosis and Treatment Market Share By Region, 2023 Vs 2031 (%)
5. Global Inflammatory Heart Disease Diagnosis Market Share By Type, 2023 Vs 2031 (%)
6. Global Imaging Tests for Inflammatory Heart Disease Market Share By Region, 2023 Vs 2031 (%)
7. Global Laboratory Tests for Inflammatory Heart Disease Market Share By Region, 2023 Vs 2031 (%)
8. Global Electrocardiography for Inflammatory Heart Disease Market Share By Region, 2023 Vs 2031 (%)
9. Global Biopsy for Inflammatory Heart Disease Market Share By Region, 2023 Vs 2031 (%)
10. Global Other Inflammatory Heart Disease Diagnosis Test Market Share By Region, 2023 Vs 2031 (%)
11. Global Inflammatory Heart Disease Treatment Market Share By Type, 2023 Vs 2031 (%)
12. Global Inflammatory Heart Disease Medications Market Share By Region, 2023 Vs 2031 (%)
13. Global Inflammatory Heart Disease Surgical Procedure Market Share By Region, 2023 Vs 2031 (%)
14. Global Inflammatory Heart Disease Diagnosis and Treatment Market Share By Region, 2023 Vs 2031 (%)
15. US Inflammatory Heart Disease Diagnosis and Treatment Market Size, 2023-2031 ($ Million)
16. Canada Inflammatory Heart Disease Diagnosis and Treatment Market Size, 2023-2031 ($ Million)
17. UK Inflammatory Heart Disease Diagnosis and Treatment Market Size, 2023-2031 ($ Million)
18. France Inflammatory Heart Disease Diagnosis and Treatment Market Size, 2023-2031 ($ Million)
19. Germany Inflammatory Heart Disease Diagnosis and Treatment Market Size, 2023-2031 ($ Million)
20. Italy Inflammatory Heart Disease Diagnosis and Treatment Market Size, 2023-2031 ($ Million)
21. Spain Inflammatory Heart Disease Diagnosis and Treatment Market Size, 2023-2031 ($ Million)
22. Rest Of Europe Inflammatory Heart Disease Diagnosis and Treatment Market Size, 2023-2031 ($ Million)
23. India Inflammatory Heart Disease Diagnosis and Treatment Market Size, 2023-2031 ($ Million)
24. China Inflammatory Heart Disease Diagnosis and Treatment Market Size, 2023-2031 ($ Million)
25. Japan Inflammatory Heart Disease Diagnosis and Treatment Market Size, 2023-2031 ($ Million)
26. South Korea Inflammatory Heart Disease Diagnosis and Treatment Market Size, 2023-2031 ($ Million)
27. Rest Of Asia-Pacific Inflammatory Heart Disease Diagnosis and Treatment Market Size, 2023-2031 ($ Million)
28. Latin America Inflammatory Heart Disease Diagnosis and Treatment Market Size, 2023-2031 ($ Million)
29. Middle East And Africa Inflammatory Heart Disease Diagnosis and Treatment Market Size, 2023-2031 ($ Million)
